Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Carlyne Cool to Pulmonary Fibrosis

This is a "connection" page, showing publications Carlyne Cool has written about Pulmonary Fibrosis.

 
Connection Strength
 
 
 
0.618
 
  1. Churg A, Sin DD, Everett D, Brown K, Cool C. Pathologic patterns and survival in chronic hypersensitivity pneumonitis. Am J Surg Pathol. 2009 Dec; 33(12):1765-70.
    View in: PubMed
    Score: 0.254
  2. Sahin H, Brown KK, Curran-Everett D, Hale V, Cool CD, Vourlekis JS, Lynch DA. Chronic hypersensitivity pneumonitis: CT features comparison with pathologic evidence of fibrosis and survival. Radiology. 2007 Aug; 244(2):591-8.
    View in: PubMed
    Score: 0.054
  3. Collard HR, Cool CD, Leslie KO, Curran-Everett D, Groshong S, Brown KK. Organizing pneumonia and lymphoplasmacytic inflammation predict treatment response in idiopathic pulmonary fibrosis. Histopathology. 2007 Jan; 50(2):258-65.
    View in: PubMed
    Score: 0.052
  4. Frankel SK, Cosgrove GP, Cha SI, Cool CD, Wynes MW, Edelman BL, Brown KK, Riches DW. TNF-alpha sensitizes normal and fibrotic human lung fibroblasts to Fas-induced apoptosis. Am J Respir Cell Mol Biol. 2006 Mar; 34(3):293-304.
    View in: PubMed
    Score: 0.048
  5. Frankel SK, Moats-Staats BM, Cool CD, Wynes MW, Stiles AD, Riches DW. Human insulin-like growth factor-IA expression in transgenic mice promotes adenomatous hyperplasia but not pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2005 May; 288(5):L805-12.
    View in: PubMed
    Score: 0.045
  6. Vourlekis JS, Schwarz MI, Cherniack RM, Curran-Everett D, Cool CD, Tuder RM, King TE, Brown KK. The effect of pulmonary fibrosis on survival in patients with hypersensitivity pneumonitis. Am J Med. 2004 May 15; 116(10):662-8.
    View in: PubMed
    Score: 0.043
  7. Cosgrove GP, Brown KK, Schiemann WP, Serls AE, Parr JE, Geraci MW, Schwarz MI, Cool CD, Worthen GS. Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis. Am J Respir Crit Care Med. 2004 Aug 01; 170(3):242-51.
    View in: PubMed
    Score: 0.043
  8. Suratt BT, Lynch DA, Cool CD, Jones RB, Brown KK. Interferon-gamma for delayed pulmonary toxicity syndrome resistant to steroids. Bone Marrow Transplant. 2003 May; 31(10):939-41.
    View in: PubMed
    Score: 0.040
  9. Kratzer A, Salys J, Nold-Petry C, Cool C, Zamora M, Bowler R, Koczulla AR, Janciauskiene S, Edwards MG, Dinarello CA, Taraseviciene-Stewart L. Role of IL-18 in second-hand smoke-induced emphysema. Am J Respir Cell Mol Biol. 2013 Jun; 48(6):725-32.
    View in: PubMed
    Score: 0.020
  10. Markopoulo KD, Cool CD, Elliot TL, Lync DA, Newell JD, Hale VA, Brown KK, Schwarz MI, Tuder RM. Obliterative bronchiolitis: varying presentations and clinicopathological correlation. Eur Respir J. 2002 Jan; 19(1):20-30.
    View in: PubMed
    Score: 0.009
  11. Fujita M, Shannon JM, Irvin CG, Fagan KA, Cool C, Augustin A, Mason RJ. Overexpression of tumor necrosis factor-alpha produces an increase in lung volumes and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2001 Jan; 280(1):L39-49.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)